PYC provides the first real tangible hope for ADPKD patients to avoid kidney failure and transplantation (if available), what price would you pay to avoid this and live/regain a normal life?
Dividing PYC current market cap by say 120,000 addressable market = $6,700 per current patient
If I was an ADPKD patient I’d pay $6,700 for a 1% chance that the drug will save me from end stage renal failure.
Would you pay $67,000 for a 10-20% chance? Would you pay $670,000 for a 80-100% chance of a cure?
I know it’s simplistic and does not take into account that PYC-003 revenues will be yearly for the life of the patient. But just a thought experiment that probably reflects a 1% awareness or probability assignment by the market to PYC’s ADPKD prospects at the moment (and that’s forgetting VP-001, PYC-001 which are both in clinic! With PYC-002 likely to join)
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)